CASI CASI Pharmaceuticals, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

CASI [NASD]

CASI Pharmaceuticals, Inc.

Healthcare | Biotechnology | USA

statements

Index	-	P/E	-	EPS (ttm)	-0.41	Insider Own	3.90%	Shs Outstand	100.92M	Perf Week	-9.34%
Market Cap	206.99M	Forward P/E	-	EPS next Y	-0.20	Insider Trans	-	Shs Float	70.96M	Perf Month	1.85%
Income	-39.70M	PEG	-	EPS next Q	-0.06	Inst Own	18.70%	Short Float	2.19%	Perf Quarter	-26.01%
Sales	10.20M	P/S	20.29	EPS this Y	-48.00%	Inst Trans	0.09%	Short Ratio	3.14	Perf Half Y	-3.51%
Book/sh	0.63	P/B	2.62	EPS next Y	20.00%	ROA	-39.40%	Target Price	-	Perf Year	-49.70%
Cash/sh	0.37	P/C	4.52	EPS next 5Y	-	ROE	-55.30%	52W Range	1.15 - 3.67	Perf YTD	-46.60%
Dividend	-	P/FCF	-	EPS past 5Y	12.10%	ROI	-64.30%	52W High	-55.04%	Beta	0.65
Dividend %	-	Quick Ratio	13.20	Sales past 5Y	180.60%	Gross Margin	5.30%	52W Low	43.48%	ATR	0.08
Employees	125	Current Ratio	13.30	Sales Q/Q	-	Oper. Margin	-	RSI (14)	47.13	Volatility	3.53% 4.94%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	46.10%	Profit Margin	-	Rel Volume	0.13	Prev Close	1.65
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Aug 10 AMC	Payout	-	Avg Volume	494.71K	Price	1.65
Recom	-	SMA20	1.73%	SMA50	-3.22%	SMA200	-21.86%	Volume	64,067	Change	0.00%

Sep-22-16

Initiated

Maxim Group

Buy

Oct-29-15

Resumed

H.C. Wainwright

Buy

$2.50 → $3

Jun-23-15

Initiated

H.C. Wainwright

Buy

$2.50

Oct-02-20 07:00AM	CASI Pharmaceuticals Announces Poster Presentation At The 2020 AABB Virtual Annual Meeting PR Newswire
Sep-29-20 07:00AM	CASI Pharmaceuticals Announces Restructuring of Partnership with Juventas Cell Therapy Ltd PR Newswire
Sep-11-20 07:00AM	CASI Pharmaceuticals, Inc. to Participate in Two Upcoming September Conferences PR Newswire
Sep-07-20 08:28AM	The CASI Pharmaceuticals (NASDAQ:CASI) Share Price Is Up 53% And Shareholders Are Holding On Simply Wall St.
Aug-26-20 05:31AM	CASI: A Change in Strategy Zacks Small Cap Research
Aug-11-20 11:30AM	CASI Pharmaceuticals Inc (CASI) Q2 2020 Earnings Call Transcript Motley Fool
Aug-10-20 07:29AM	CASI Pharmaceuticals: Q2 Earnings Insights Benzinga
07:00AM	CASI Pharmaceuticals Announces Second Quarter 2020 Financial Results PR Newswire
Jul-22-20 09:05AM	CASI Pharmaceuticals Announces Pricing Of $38,000,000 Public Offering Of Common Stock PR Newswire -14.80%
Jul-21-20 04:01PM	CASI Pharmaceuticals Announces Proposed Public Offering Of Common Stock PR Newswire
Jul-09-20 09:39AM	Here's What CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Shareholder Ownership Structure Looks Like Simply Wall St.
Jun-08-20 07:00AM	CASI Pharmaceuticals Announces Submission Of Clinical Trial Application (IND) To Conduct Phase 1 Study For Anti-38 Monoclonal Antibody Program PR Newswire
Jun-02-20 07:00AM	CASI Pharmaceuticals To Present At The Jefferies 2020 Healthcare Conference PR Newswire
May-31-20 05:38PM	Do Hedge Funds Love CASI Pharmaceuticals Inc (CASI)? Insider Monkey
May-25-20 06:14AM	Wei-Wu He Is The Chairman & CEO of CASI Pharmaceuticals, Inc. (NASDAQ:CASI) And They Just Picked Up 32% More Shares Simply Wall St.
May-14-20 06:47AM	Earnings Update: CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Just Reported And Analysts Are Boosting Their Estimates Simply Wall St.
May-12-20 06:43AM	Upgrade: Analysts Just Made A Notable Increase To Their CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Forecasts Simply Wall St.
May-11-20 07:00AM	CASI Pharmaceuticals Announces First Quarter 2020 Financial Results PR Newswire
May-08-20 09:05AM	CASI: A Change in Strategy Zacks Small Cap Research
Apr-07-20 07:00AM	CASI Pharmaceuticals To Present at 2020 Solebury Trout Virtual Investor Conference PR Newswire -5.15%
Mar-31-20 07:05AM	CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Analysts Just Slashed This Year's Estimates Simply Wall St.
Mar-29-20 08:08AM	Insider Buying: The CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Chairman & CEO Just Bought US$1.1m Worth Of Shares Simply Wall St.
Mar-16-20 07:00AM	CASI Pharmaceuticals Announces Full Year 2019 Financial Results PR Newswire -8.86%
Mar-02-20 06:03AM	Did Changing Sentiment Drive CASI Pharmaceuticals's (NASDAQ:CASI) Share Price Down By 47%? Simply Wall St.
Feb-21-20 07:46AM	The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion Benzinga
Feb-07-20 10:49AM	Ligand (LGND) Q4 Earnings & Revenues Top Estimates, Stock Up Zacks
Feb-04-20 07:51AM	The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares Benzinga
Jan-26-20 08:33AM	What You Must Know About CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Beta Value Simply Wall St.
Dec-20-19 05:27AM	Have Insiders Been Buying CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Shares? Simply Wall St.
Dec-03-19 09:00PM	CASI Pharmaceuticals Announces China NMPA Approval Of CNCT19 (CD19 CAR-T) Clinical Trial Applications PR Newswire
Nov-14-19 05:17AM	CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Path To Profitability Simply Wall St.
Nov-12-19 07:00AM	CASI Pharmaceuticals Announces Third Quarter 2019 Financial Results PR Newswire
Nov-07-19 07:00AM	CASI Pharmaceuticals Enters Exclusive China Distribution License Agreement For Octreotide Long Acting Injectable (LAI) Microsphere For Neuroendocrine Cancers And Acromegaly PR Newswire
Nov-06-19 09:33AM	Ligand's (LGND) Q3 Earnings Miss Estimates, EPS View Down Zacks
Sep-19-19 07:00AM	CASI Pharmaceuticals Announces The Promotion Of Larry Zhang To President PR Newswire
Sep-16-19 06:00AM	China NMPA Accepts Clinical Trial Application For CASI's CD19 CAR-T-Product PR Newswire
Sep-03-19 07:00AM	CASI Pharmaceuticals, Inc. To Present At The 2019 H.C. Wainwright 21st Annual Global Investment Conference PR Newswire
Aug-20-19 07:15PM	Casi Pharmaceuticals Inc (CASI) CEO Wei-wu He Bought $64,000 of Shares GuruFocus.com
Aug-19-19 12:22PM	What Kind Of Shareholders Own CASI Pharmaceuticals, Inc. (NASDAQ:CASI)? Simply Wall St.
Aug-16-19 10:20AM	CASI: CASI launches Evomela - first commercial product Zacks Small Cap Research
Aug-15-19 07:15PM	Casi Pharmaceuticals Inc (CASI) CEO Wei-wu He Bought $507,200 of Shares GuruFocus.com
Aug-12-19 03:03PM	Rockville biopharma to sell first product on market in 28 years but not in the U.S. American City Business Journals
07:00AM	CASI Pharmaceuticals Announces Launch of EVOMELA® (melphalan for injection) in China PR Newswire
Aug-09-19 07:00AM	CASI Pharmaceuticals Announces Second Quarter and First Half 2019 Financial and Business Results PR Newswire
Jul-31-19 10:44AM	Ligand (LGND) Stock Down Despite Q2 Earnings & Sales Beat Zacks
Jun-17-19 07:00AM	CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy PR Newswire
Jun-03-19 07:00AM	CASI Pharmaceuticals To Present At The 2019 BIO International Convention PR Newswire
May-20-19 09:45AM	CASI: Making headway towards commercialization Zacks Small Cap Research
May-15-19 07:00AM	CASI Pharmaceuticals Announces First Quarter 2019 Financial and Business Results PR Newswire
May-13-19 10:00AM	CASI: Initiating coverage Leveraging pharmaceutical opportunities in China and beyond Zacks Small Cap Research -5.36%
May-03-19 08:42AM	Ligand (LGND) Q1 Earnings & Sales Fall Y/Y, Stock Down Zacks
Apr-18-19 04:15PM	INVESTOR ALERT: Monteverde & Associates PC Launches an Investigation of the Board of Directors and Officers PR Newswire
Apr-17-19 07:00AM	CASI Pharmaceuticals In-Licenses Exclusive Worldwide Rights to Novel Anti-CD38 Monoclonal Antibody Program From Black Belt Therapeutics PR Newswire
Apr-02-19 07:00AM	CASI Pharmaceuticals Announces The Appointment Of Wei-Wu He, Ph.D., Executive Chairman, To The Role Of Chief Executive Officer PR Newswire -5.00%
Mar-29-19 07:00AM	CASI Pharmaceuticals Announces Fourth Quarter And Full Year 2018 Financial Results And Business Results PR Newswire -9.46%
Mar-13-19 07:00AM	CASI Pharmaceuticals Announces Exclusive Distribution Partner For Melphalan Hydrochloride For Injection (EVOMELA®) In China PR Newswire
Mar-07-19 07:00AM	CASI Pharmaceuticals Announces China National Medical Products Administration (NMPA) Approval Of CTA To Conduct Registration Trial For MARQIBO® PR Newswire
Feb-26-19 08:14AM	When Will CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Turn A Profit? Simply Wall St.
Feb-20-19 08:15AM	Report: Developing Opportunities within Pure Storage, Flowers Foods, Cognex, CASI Pharmaceuticals, Ellie Mae, and Douglas Emmett Future Expectations, Projections Moving into 2019 GlobeNewswire
Feb-19-19 07:00AM	CASI Pharmaceuticals Announces China National Medical Products Administration (NMPA) Approval Of CTA To Conduct Confirmatory Clinical Trial For ZEVALIN® PR Newswire
Feb-06-19 07:00AM	CASI Pharmaceuticals to Present at the BIO CEO & Investor Conference PR Newswire
Dec-28-18 11:45AM	These 4 Healthcare Stocks Are Heating Up ACCESSWIRE
Dec-26-18 09:32AM	Do Institutions Own Shares In CASI Pharmaceuticals, Inc. (NASDAQ:CASI)? Simply Wall St. +7.23%
Dec-03-18 09:15AM	The 4 Healthcare Stocks To Watch On Monday ACCESSWIRE +5.31%
08:12AM	CASI Pharmaceuticals Announces China Market Approval Of Melphalan Hydrochloride For Injection (Trademark: EVOMELA®) PR Newswire
Nov-30-18 04:05PM	Chinese biotech stocks hit by a double whammy, which means its time to buy MarketWatch +10.74%
Nov-28-18 08:40AM	Report: Exploring Fundamental Drivers Behind CASI Pharmaceuticals, Booking, Enstar Group, Madrigal Pharmaceuticals, Dermira, and Kaiser Aluminum New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-16-18 07:00AM	CASI Pharmaceuticals To Build GMP Manufacturing Site In Wuxi, China PR Newswire +16.48%
Nov-14-18 07:00AM	CASI Pharmaceuticals Announces Third Quarter and First Nine Months 2018 Financial and Business Results PR Newswire
Oct-24-18 08:00AM	Todays Research Reports on Stocks to Watch: CASI Pharmaceuticals and Therapix Biosciences ACCESSWIRE -15.63%
Oct-23-18 03:47PM	Why CASI Pharmaceuticals Inc. Is Rocketing Higher Today Motley Fool +20.96%
02:30PM	3 Healthcare Stocks Trending Higher On News ACCESSWIRE
07:05AM	CASI Pharmaceuticals Acquires HBV ANDA from Laurus Labs Limited PR Newswire
Oct-18-18 08:40AM	Detailed Research: Economic Perspectives on Beacon Roofing Supply, Rowan Companies, CASI Pharmaceuticals, LivePerson, Impinj, and Tredegar What Drives Growth in Today's Competitive Landscape GlobeNewswire
Oct-02-18 07:00AM	CASI Pharmaceuticals Announces Appointment Of President To Its China Operations To Lead Commercialization PR Newswire
Sep-28-18 07:00AM	CASI Pharmaceuticals Announces Appointment Of Chief Financial Officer PR Newswire -9.50%
Sep-14-18 07:00AM	CASI Pharmaceuticals Announces $48.5 Million Private Placement PR Newswire
Aug-27-18 08:20AM	Factors of Influence in 2018, Key Indicators and Opportunity within Steelcase, SecureWorks, Cleveland-Cliffs, Tredegar, Warrior Met Coal, and CASI Pharmaceuticals New Research Emphasizes Economic Growth GlobeNewswire
Aug-14-18 07:00AM	CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results PR Newswire
Jul-05-18 07:43AM	Benzinga's Daily Biotech Pulse: Realm Therapeutics To List On Nasdaq, CASI Pharma Added To Russell 2000 Index Benzinga
Jul-03-18 01:05PM	CASI Pharmaceuticals Added To Russell 2000®, 3000® And Microcap® Indexes PR Newswire
Jun-25-18 08:00AM	Report: Exploring Fundamental Drivers Behind Cabot Oil & Gas, Chesapeake Lodging Trust, CASI Pharmaceuticals, Peabody Energy, Alcoa, and Edwards Lifesciences New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jun-21-18 04:14PM	Here's Why CASI Pharmaceuticals Rose as Much as 31.6% Today Motley Fool
07:00AM	CASI Pharmaceuticals Enters Strategic Partnering And Contract Manufacturing Agreement With Yiling Wanzhou International Pharmaceuticals For Entecavir And Cilostazol PR Newswire
May-31-18 08:30AM	Free Technical Insights on CASI Pharma and Three Other Biotech Stocks ACCESSWIRE -5.65%
May-29-18 07:00AM	CASI Pharmaceuticals To Present At The BIO International Convention PR Newswire -5.89%
May-15-18 07:00AM	CASI Pharmaceuticals Announces First Quarter 2018 Financial And Business Results PR Newswire
May-07-18 07:30AM	Detailed Research: Economic Perspectives on CASI Pharmaceuticals, Energy Transfer Partners, Cypress Semiconductor, Xcel Energy, Ironwood Pharmaceuticals, and KalVista Pharmaceuticals What Drives Growth in Today's Competitive Landscape GlobeNewswire
May-02-18 12:01PM	Harry Boxers four biotech stocks to watch today MarketWatch +11.62%
Apr-30-18 04:47PM	Can These Top-Performing Biotech Stocks Keep Climbing? Motley Fool
Apr-16-18 07:40AM	Blog Exposure - Enanta Pharma Announced Presentation of New Data for Core Inhibitor for Hepatitis B Virus and FXR Agonist EDP-305 for NASH ACCESSWIRE
Apr-08-18 07:17AM	What Stocks Perform Well in the Midst of a Trade War? Motley Fool
Apr-06-18 04:23PM	Here's Why CASI Pharmaceuticals Rose as Much as 23.4% Today Motley Fool +13.98%
Apr-05-18 08:00AM	CASI Pharmaceuticals Provides Update On EVOMELA® PR Newswire
Apr-03-18 07:00AM	CASI Pharmaceuticals To Present At The H.C. Wainwright Global Life Sciences Conference PR Newswire +47.54%
Mar-29-18 07:00AM	CASI Pharmaceuticals Announces Fourth Quarter And Full Year 2017 Financial Results PR Newswire +9.45%
Mar-21-18 08:10AM	Todays Research Reports on Trending Tickers: Arena Pharmaceuticals and CASI Pharmaceuticals ACCESSWIRE
Mar-20-18 09:29AM	CASI Pharmaceuticals Announces $50 Million Private Placement To Prepare Company For Commercialization In China PR Newswire +21.81%
Mar-05-18 08:30AM	Factors of Influence in 2018, Key Indicators and Opportunity within Cypress Semiconductor, Abaxis,Inc, Universal Health Services, CASI Pharmaceuticals, Energy Transfer Partners, and Arconic New Research Emphasizes Economic Growth GlobeNewswire
Feb-09-18 07:00AM	CASI Pharmaceuticals to Present at the BIO CEO & Investor Conference PR Newswire

CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical products and various therapeutics in China, the United States, and internationally. The company's product pipeline includes EVOMELA, a melphalan hydrochloride for injection primarily for use as a high-dose conditioning treatment prior to hematopoietic progenitor cell transplantation in patients with multiple myeloma. Its product pipeline also comprise CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-cell non-Hodgkin lymphoma; CID-103, an anti-CD38 monoclonal antibody being for the treatment of patients with multiple myeloma; ZEVALIN, a CD20-directed radiotherapeutic antibody, to treat patients with NHL; and Thiotepa, a chemotherapeutic agent, which has multiple indications including use as a conditioning treatment for use prior to hematopoietic stem cell transplantation. In addition, the company offers MARQIBO, a microtubule inhibitor, approved by the FDA for the treatment of adult patients with Philadelphia chromosome-negative ALL; and Octreotide LAI formulations for the treatment of acromegaly and for the control of symptoms associated with various neuroendocrine tumours, as well as developing a portfolio of 25 FDA-approved abbreviated new drug applications. It has licensing agreements with Black Belt Therapeutics Limited, Juventas Cell Therapy Ltd., and Pharmathen Global BV. The company was formerly known as EntreMed, Inc. and changed its name to CASI Pharmaceuticals, Inc. in June 2014. CASI Pharmaceuticals, Inc. was founded in 1991 and is based in Rockville, Maryland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zhang Larry	President	Jul 22	Buy	1.90	20,153	38,291	20,153	Jul 24 04:05 PM
He Wei-Wu	Chairman and CEO	Jul 22	Buy	1.90	1,200,000	2,280,000	7,532,347	Jul 24 04:03 PM
He Wei-Wu	Chairman and CEO	Jul 22	Buy	1.90	2,952,426	5,609,609	4,836,523	Jul 24 04:03 PM
He Wei-Wu	Chairman and CEO	May 20	Buy	2.37	56,464	133,820	1,884,097	May 21 05:01 PM
He Wei-Wu	Chairman and CEO	May 19	Buy	2.03	29,801	60,496	1,827,663	May 21 05:01 PM
He Wei-Wu	Chairman and CEO	May 18	Buy	2.02	338,932	684,643	1,797,832	May 19 05:55 PM
He Wei-Wu	Chairman and CEO	May 15	Buy	1.82	100,000	182,000	1,458,900	May 19 05:55 PM
He Wei-Wu	Chairman and CEO	Mar 27	Buy	2.08	6,880	14,310	1,358,900	Mar 30 04:01 PM
He Wei-Wu	Chairman and CEO	Mar 26	Buy	2.09	328,095	685,719	1,352,020	Mar 27 05:07 PM
He Wei-Wu	Chairman and CEO	Mar 25	Buy	1.94	196,398	381,012	1,023,925	Mar 27 05:07 PM
He Wei-Wu	Chairman and CEO	Mar 19	Buy	1.57	234,488	368,146	6,332,347	Mar 19 05:39 PM
He Wei-Wu	Chairman and CEO	Mar 18	Buy	1.52	501,322	762,009	6,097,859	Mar 19 05:39 PM
He Wei-Wu	Chairman and CEO	Mar 17	Buy	1.50	264,192	396,288	5,596,537	Mar 19 05:39 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience